Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07442513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study employs a prospective, randomized, double-blind, placebo-controlled design. It aims to compare the efficacy of etamsylate versus placebo in preventing bleeding complications in patients with thrombocytopenia following hematopoietic stem cell transplantation.
Trial Details
NCT Number NCT07442513
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions
(from sponsor)		 Hematopoietic Stem Cell Transplantation, Thrombocytopenia
Related terms Thrombocytopenia
Enrollment 404 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov